|
Cost-effectiveness analysis of aripiprazole augmentation treatment of patients with major depressive disorder compared to olanzapine and quetiapine augmentation in Turkey: a microsimulation approach |
Saylan M, Treur MJ, Postema R, Dilbaz N, Savas H, Heeg BM, Drost PB |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Saylan M, Treur MJ, Postema R, Dilbaz N, Savas H, Heeg BM, Drost PB. Cost-effectiveness analysis of aripiprazole augmentation treatment of patients with major depressive disorder compared to olanzapine and quetiapine augmentation in Turkey: a microsimulation approach. Value in Health Regional Issues 2013; 2(2): 171-180 Indexing Status Subject indexing assigned by CRD MeSH Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quinolones AccessionNumber 22013045683 Date bibliographic record published 31/10/2013 |
|
|
|